Ekansh Mittal of Katalyst Wealth keeps a low profile. However, his stock picks have done all the talking for him with a mind-blowing return of 206% in 30 months which works out to a CAGR of 55%
Posts tagged UBS
Is Shilpa Medicare Giving The Same Opportunity That JB Chem Did?
Shilpa Medicare’s Q1FY15 results sent a chill down the spine of its shareholders and their knee-jerk reaction was to dump the stock, sending it reeling down 10%. However, if you peer closely at the results, you will realize that it is an aberration and an opportunity to tuck into the stock says Daljeet Kohli
Recent Comments